Thymus transplantation
Thymus transplantation | |
---|---|
ICD-9-CM | 07.94 |
Thymus transplantation is a form of organ transplantation where the thymus is moved from one body to another. It is used in certain immunodeficiencies, such as DiGeorge Syndrome.[1]
Indications
Thymus transplantation is used to treat infants with
Nezelof syndrome is another thymus-related disease where it can be used.[3]
Thymus transplantation can also be used in pediatric patients with a Foxn1 deficiency.[4]
Co-transplantation with other organs
In the 2000s, promising animal experiments into transplanting thymic tissue and another organ at the same time were carried out, in order to improve the recipient's tolerance of the transplanted organ, and to reduce the need for immunosuppressing drugs like tacrolimus. Such trials have been performed with kidney and heart transplants, drastically extending the time the animals were surviving without immunosuppressing drugs.[5] The first human heart-and-thymus co-transplantation was performed on Easton Sinnamon in 2022, a newborn who suffered from both a lack of T cells, and a serious heart defect. Depending on the development, it is planned to wean him off immunosuppressant drugs, but it remains to be seen whether the same technique is viable in adults, as the thymus shrinks with age, with the bone marrow taking over T cell production.[6]
Effects and prognosis
A study of 54 DiGeorge syndrome infants resulted in all tested subjects having developed polyclonal T-cell repertoires and proliferative responses to mitogens. The procedure was well tolerated and resulted in stable immunoreconstitution in these infants. It had a survival rate of 75%, having a follow-up as long as 13 years.[2]
Complications include an increased susceptibility to infections while the T cells have not yet developed, rashes and erythema.[2]
Graft-versus-host disease
Theoretically, thymus transplantation could cause two types of graft-versus-host disease (GVHD): First, it could cause a donor T cell-related GVHD, because of T cells from the donor that are present in the transplanted thymus that recognizes the recipient as foreign. Donor T cells can be detected in the recipient after transplantation, but there is no evidence of any donor T cell-related graft-versus-host disease.[2][7]
Second, a thymus transplantation can cause a non-donor T cell-related GVHD because the recipients
References
- PMC 7120154, retrieved 2024-04-14
- ^ PMID 17284531.
- PMID 307221– via NIH.
- PMID 20236866.
- PMID 32352934
- ^ Ahmed T (2022-03-10). "Baby gets first heart and thymus transplant, possibly eliminating need for dangerous lifelong medication". CNN.
- PMID 10523153.
- PMID 11160231.
- ^ Thymus Transplantation
Book Thymus Gland Pathology
Publisher Springer Milan
DOI 10.1007/978-88-470-0828-1
Copyright 2008
ISBN 978-88-470-0827-4(Print) 978-88-470-0828-1 (Online) DOI 10.1007/978-88-470-0828-1_30 Pages 255-267